Trials / Completed
CompletedNCT04697537
Ultrasound-guided Regional Anesthesia vs Local Infiltration Anesthesia With Dexmedetomidine and Ropivacaine
Dexmedetomidine as Adjunct Medication to Local Infiltration Anesthesia (LIA) vs Ultrasound-Guided Regional Anesthesia (USRA) in Regard to Patients' Need for Opioids, Wellbeing, Satisfaction, and Knee Functionality in Knee-endoprosthetics
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Medical University of Graz · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the Impact of dexmedetomidine as an adjunct for local infiltrations analgesia and ultrasound-based regional anaesthesia as pain medication in regard to patients' opioid need the first 48 hours after the total knee replacement operation.
Detailed description
Evaluation of the Impact of dexmedetomidine as an adjunct for local infiltrations analgesia and ultrasound-based regional anaesthesia as pain medication in regard to patients' opioid need the first 48 hours after the total knee replacement operation. Secondary objectives are: Pain assesment, Pain medication necessary, functionality of the prothesis, satisfaction, wellbeing, postoperative discomforts, complications (delirium, allergic reactions, cardiopulmonary decompensation), procedure specific time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ultrasound guided regional anesthesia | Applied perineurally preoperatively ultrasound guided regional anesthesia |
| DRUG | Local infiltration analgesia | Applied in the wound intraoperatively from the orthopedics |
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2021-04-09
- Completion
- 2021-04-09
- First posted
- 2021-01-06
- Last updated
- 2021-04-14
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT04697537. Inclusion in this directory is not an endorsement.